selected publications
-
Phase II trial of saracatinib (AZD0530), an oral SRC-inhibitor for the treatment of patients with hormone receptor-negative metastatic breast cancer.
Clinical breast cancer.
2011
Academic Article
GET IT
Times cited: 116 -
The lung in the immunocompromised host: diagnostic methods.
Respiration; international review of thoracic diseases.
1999
Information Resource
GET IT
Times cited: 4 -
Dietary peptides improve wound healing following surgery.
Nutrition (Burbank, Los Angeles County, Calif.).
1998
Academic Article
GET IT
Times cited: 41 -
Hand-held blood gas analyzer is accurate in the critical care setting.
Critical care medicine.
1996
Academic Article
GET IT
Times cited: 37 -
Pulmonary infections in immunosuppressed patients.
Current opinion in pulmonary medicine.
1995
Information Resource
GET IT
Times cited: 3